Feed / Theme
Confirmed

Healthcare REITs and Banks

33 names are moving together; 70% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
BMYBristol-Myers Squibb CompanyHealthcare-0.7%Group member
AZNAstraZeneca PLCHealthcare-3.8%Group member
YPFYPF Sociedad AnonimaEnergy+1.1%Group member
GSKGSK plcHealthcare+0.6%Group member
WPCW. P. Carey Inc. REITReal Estate+0.9%Group member
VOYAVoya Financial, Inc.Financial Services+1.1%Group member
BUDAnheuser-Busch Inbev SA SponsorConsumer Defensive+0.3%Group member
GLGlobe Life Inc.Financial Services+0.1%Group member
ALHCAlignment Healthcare, Inc.Healthcare-5.8%Group member
PCRXPacira BioSciences, Inc.Healthcare-0.1%Group member
IVTInvenTrust Properties Corp.Real Estate+0.0%Group member
JBSSJohn B. Sanfilippo & Son, Inc.Consumer Defensive+1.1%Group member
KRGKite Realty Group TrustReal Estate+0.4%Group member
HRHealthcare Realty Trust IncorpoReal Estate+0.0%Group member
BRXBrixmor Property Group Inc.Real Estate+0.3%Group member
CFRCullen/Frost Bankers, Inc.Financial Services+1.1%Group member
CMCSAComcast CorporationCommunication Services+0.9%Group member
RBCAARepublic Bancorp, Inc.Financial Services-0.4%Group member
GIPRGeneration Income Properties InReal Estate+1010.3%Group member
BCPCBalchem CorporationBasic Materials-0.7%Group member
ORealty Income CorporationReal Estate+0.2%Group member
TGTTarget CorporationConsumer Defensive+2.2%Group member
GLIBKLiberty Capital Corporation - SCommunication Services+0.6%Group member
PECOPhillips Edison & Company, Inc.Real Estate-0.3%Group member

Why we believe this

Cohort

33 names

Participation

70% this session

Observed history

1 daily builds

Filing coverage

29/33 members

credit / rates affecting interest expense

The accounting method for reflecting the Notes on our condensed consolidated balance sheet, accruing interest expense for the Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.

ALNY 10-Q

restructuring

Any impairment of these sublicensed rights could result in reduced revenues under our collaboration agreements or result in termination of an agreement by one or more of our collaborators.

ALNY 10-Q

demand / volume

nded December 31, 2025, compared to the year ended December 31, 2024, primarily due to growth from AMVUTTRA revenues driven by increased patient demand, mainly in patients with ATTR-CM in the U.S., which was partially offset by a decreased number of patients on ONPATTRO, and due to growth from an increased number of patients on GIVLAARI and OXLUMO.

ALNY 10-K

Healthcare REITs and Banks can stay leader-led if AVAH and the next software names fail to join while ALNY keeps moving.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.